Список литературы

1. Gaitanis G., Magiatis P., Hantschke M. et al. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev. 2012; 25 (1): 106 - 141. doi: 10.1128/CMR.00021-11.

2. Gupta A.K., Foley K.A. Antifungal treatment for pityriasis versicolor. J Fungi (Basel). 2015; 1 (1): 13 - 29. doi: 10.3390/jof1010013.

3. He S.M., Du W.D., Yang S. et al. The genetic epidemiology of tinea versicolor in China. Mycoses. 2008; 51 (1): 55 - 62. doi: 10.1111/j.1439-0507.2007.01437.x.

4. Медицинские лабораторные технологии: Руководство по клинической лабораторной диагностике в 2 т. Том 2. Под ред. А.И. Карпищенко. ГЭОТАР-Медиа - 792 с. (страница 577).

5. Сергеев А.Ю., Сергеев Ю.В. Грибковые инфекции: Руководство для врачей. - М.: Бином, 2008. - 480 с.

6. Gupta AK, Batra R, Bluhm R, Faergemann J. Pityriasis versicolor. Dermatol Clin. 2003; 21 (3): 413 - 429, v - vi. doi: 10.1016/s0733-8635(03)00039-1.

7. Renati S., Cukras A., Bigby M. Pityriasis versicolor. BMJ. 2015 Apr 7; 350: h1394. doi: 10.1136/bmj.h1394.

8. Rivard S.C. Pityriasis versicolor: avoiding pitfalls in disease diagnosis and therapy. Mil Med. 2013; 178 (8): 904 - 906. doi: 10.7205/MILMED-D-13-00057.

9. Moya-Salazar J, R, Rojas-Zumaran V, Quispe WC. Fungal infections in HIV-positive Peruvian patients: Could the Venezuelan migration cause a health warning related-infectious diseases? J Infectiology. 2019; 2 (2): 3 - 10.

10. Галлямова Ю.А. Отрубевидный лишай. Лечащий врач. 2010; 5: 38 - 41.

11. Aly R, Berger T. Common superficial fungal infections in patients with AIDS. Clin Infect Dis. 1996 May; 22 Suppl 2: S128 - 32. doi: 10.1093/clinids/22.supplement_2.s128.

12. Корнишева В.Г., Могилева Е.Ю. Микозы при ВИЧ-инфекции. Обзор литературы. Проблемы медицинской микологии. 2013; 15 (4): 10 - 19.

13. Нагибина М.В., Мартынова Н.Н., Преснякова О.А. и др. Особенности клиники и лечения поражений кожи при ВИЧ-инфекции. Лечащий врач. 2015; 2: 83.

14. Asawanonda P., Taylor C.R. Wood's light in dermatology. Int J Dermatol. 1999; 38(11): 801 - 807.

15. Ponka D., Baddar F. Wood lamp examination. Can Fam Physician. 2012; 58 (9): 976. PMID: 22972730.

16. Keddie F. Clinical signs in tinea versicolor. Arch Dermatol. 1963; 87: 641 - 642. doi: 10.1001/archderm.1963.01590170099017.

17. Степанова Ж.В. Микозы гладкой кожи. Consilium Medicum. 2000; 2 (5): 199 - 202.

18. Balwada R.P., Jain V.K., Dayal S. A double-blind comparison of 2% ketoconazole and 1% clotrimazole in the treatment of pityriasis versicolor. Indian J Dermatol Venereol Leprol. 1996; 62 (5): 298 - 300. PMID: 20948094.

19. Savin R.C., Horwitz S.N. Double-blind comparison of 2% ketoconazole cream and placebo in the treatment of tinea versicolor. J Am Acad Dermatol. 1986; 15 (3): 500 - 503. doi: 10.1016/s0190-9622(86)70200-4.

20. Goodless D.R., Ramos-Caro F.A., Flowers F.P. Ketoconazole in the treatment of pityriasis versicolor: international review of clinical trials. DICP. 1991; 25 (4): 395 - 398. doi: 10.1177/106002809102500411.

21. Sarkar S., Sengupta D., Basak S. et al. Comparative assessment of the efficacy of topical ketoconazole and topical luliconazole in cases of pityriasis versicolor at a tertiary care hospital in eastern India: A prospective, open, randomized controlled trial. Indian Dermatol Online J. 2016; 7 (4): 335 - 336. doi: 10.4103/2229-5178.185471.

22. Lange D.S., Richards H.M., Guarnieri J. et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol. 1998; 39 (6): 944 - 950. doi: 10.1016/s0190-9622(98)70267-1.

23. Дерматовенерология. Национальное руководство/Под ред. Ю.К. Скрипкина, Ю.С. Бутова, О.Л. Иванова. - М.: ГЭОТАР-Медиа, 2013. - 1024 с.

24. el-Zawahry M, Moawad MK, Soliman M. Topical treatment of dermatomycoses with Canesten cream, a new antimycotic compound. Mykosen. 1973 Nov 1; 16(11): 363 - 5. doi: 10.1111/j.1439-0507.1973.tb04072.x.

25. Clayton R., Du Vivier A., Savage M. Double-blind trial of 1% clotrimazole cream and Whitfield ointment in the treatment of pityriasis versicolor. Arch Dermatol. 1977; 113 (6): 849 - 850. doi: 10.1001/archderm.1977.01640060145029.

26. Spiekermann P.H., Young M.D. Clinical evaluation of clotrimazole. A broad-spectrum antifungal agent. Arch Dermatol. 1976; 112 (3): 350 - 352. doi: 10.1001/archderm.1976.01630270030007.

27. Van Cutsem J, Reyntjens A. Miconazole treatment of pityriasis versicolor a review. Mykosen. 1978; 21 (3): 87 - 91. doi: 10.1111/j.1439-0507.1978.tb01618.x.

28. Tanenbaum L., Anderson C., Rosenberg M.J., Akers W. 1% sulconazole cream v 2% miconazole cream in the treatment of tinea versicolor. A double-blind, multicenter study. Arch Dermatol. 1984; 120 (2): 216 - 219. PMID: 6364994.

29. Fredriksson T. Treatment of dermatomycoses with topical tioconazole and miconazole. Dermatologica. 1983; 166 Suppl 1: 14 - 19. doi: 10.1159/000249910.

30. Потекаев Н.Н., Новиков А.Г. Разноцветный лишай. Современный взгляд на старую проблему. Российский журнал кожных и венерических болезней. 2004; 2: 42 - 45.

31. Котрехова Л.П., Вашкевич А.А., Цурупа Е.Н., Резцова П.А. Раствор и крем нафтифина гидрохлорида в терапии отрубевидного лишая. Вестник дерматологии и венерологии. 2016; 2: 103 - 109.

32. Дерматовенерология. Чеботарев В.В., Тамразова О.Б., Чеботарева Н.В., Одинец А.В. М.: ГЭОТАР-Медиа, 2013. - 584 с.

33. Aste N., Pau M., Pinna A.L. et al. Clinical efficacy and tolerability of terbinafine in patients with pityriasis versicolor. Mycoses. 1991; 34 (7-8): 353 - 357. doi: 10.1111/j.1439-0507.1991.tb00676.x.

34. Faergemann J., Hersle K., Nordin P. Pityriasis versicolor: clinical experience with Lamisil cream and Lamisil DermGel. Dermatology. 1997; 194 Suppl 1: 19 - 21. doi: 10.1159/000246178.

35. Rad F., Nik-Khoo B., Yaghmaee R., Gharibi F. Terbinafin 1% cream and ketoconazole 2% cream in the treatment of pityriasis versicolor: A randomized comparative clinical trial. Pak J Med Sci. 2014; 30 (6): 1273 - 1276. doi: 10.12669/pjms.306.5509.

36. Котрехова Л.П., Васильева Н.В., Разнатовский К.И., Пиотровская И.В. Клиническая эффективность и безопасность тербинафина (ламизил спрей, ламизил дермгель) в лечении отрубевидного лишая. Клиническая дерматология и венерология. 2007; 3: 35 - 38.

37. Gip L. Comparison of oxiconazole (Ro 13-8996) and econazole in dermatomycoses. Mykosen. 1984; 27 (6): 295, 298 - 302. doi: 10.1111/j.1439-0507.1984.tb02033.x.

38. Nasarre J, Umbert P, Herrero E et al. Therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of Pityriasis versicolor. Arzneimittelforschung. 1992; 42(5A): 764 - 767.

39. Tatavarthi L, Ramachandra B, Subba RD, Srinivasulu G. Clinical evaluation of efficacy of sertaconazole 2% cream in treatment of Pityriasis versicolor and a comparision with that of clotrimazole 1% cream. J Evol Med Dent Sci. 2015; 4 (27): 4668 - 4675. DOI: 10.14260/jemds/2015/675.

40. Croxtall JD, Plosker GL. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology. Drugs. 2009; 69 (3): 339 - 359. doi: 10.2165/00003495-200969030-00009.

41. Hickman J.G. A double-blind, randomized, placebo-controlled evaluation of short-term treatment with oral itraconazole in patients with tinea versicolor. J Am Acad Dermatol. 1996; 34 (5 Pt 1): 785 - 787. doi: 10.1016/s0190-9622(96)90014-6.

42. Roseeuw D, Willemsen M, Kint RT, Peremans W, Mertens RL, Van Cutsem J. Itraconazole in the treatment of superficial mycoses--a double-blind study vs. placebo. Clin Exp Dermatol. 1990 Mar; 15(2): 101 - 4. doi: 10.1111/j.1365-2230.1990.tb02041.x.

43. Delescluse J. Itraconazole in tinea versicolor: a review. J Am Acad Dermatol. 1990 Sep; 23(3 Pt 2): 551 - 4. doi: 10.1016/0190-9622(90)70252-d.

44. Faergemann J. Treatment of pityriasis versicolor with itraconazole: a double-blind placebo controlled study. Mycoses. 1988; 31 (7): 377 - 379. doi: 10.1111/j.1439-0507.1988.tb04435.x.

45. Savin R.C. Systemic ketoconazole in tinea versicolor: a double-blind evaluation and 1-year follow-up. J Am Acad Dermatol. 1984; 10 (5 Pt 1): 824 - 830. doi: 10.1016/s0190-9622(84)70098-3.

46. Goodless DR, Ramos-Caro FA, Flowers FP. Ketoconazole in the treatment of pityriasis versicolor: international review of clinical trials. DICP. 1991; 25 (4): 395 - 398. doi: 10.1177/106002809102500411.

47. Urcuyo FG, Zaias N. The successful treatment of pityriasis versicolor by systemic ketoconazole. J Am Acad Dermatol. 1982 Jan; 6(1): 24 - 5. doi: 10.1016/s0190-9622(82)80198-9.

48. Farschian M., Yaghoobi R., Samadi K. Fluconazole versus ketoconazole in the treatment of tinea versicolor. J Dermatolog Treat. 2002; 13 (2): 73 - 76. doi: 10.1080/095466302317584421.

49. Amer MA., Egyptian Fluconazole Study Group. Fluconazole in the treatment of tinea versicolor. Int J Dermatol. 1997;36 (12): 940 - 942. doi: 10.1046/j.1365-4362.1997.00213.x.

50. Yazdanpanah MJ, Azizi H, Suizi B. Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor. Mycoses. 2007 Jul; 50(4): 311 - 3. doi: 10.1111/j.1439-0507.2007.01361.x.

51. M, Durdu M, HR. Oral fluconazole in the treatment of tinea versicolor. J Dermatol. 2005 Jan; 32(1): 19 - 21. doi: 10.1111/j.1346-8138.2005.tb00707.x.

52. Bhogal CS, Singal A, Baruah MC. Comparative efficacy of ketoconazole and fluconazole in the treatment of pityriasis versicolor: a one year follow-up study. J Dermatol. 2001; 28 (10): 535 - 539. doi: 10.1111/j.1346-8138.2001.tb00026.x.

53. Faergemann J., Gupta A.K., Al Mofadi A. et al. Efficacy of itraconazole in the prophylactic treatment of pityriasis (tinea) versicolor. Arch Dermatol. 2002; 138 (1): 69 - 73. doi: 10.1001/archderm.138.1.69.